FDA Q&A Document on Addressing Misinformation About Devices and Drugs: General Communication
The new article explains the matters related to general medical product communication in the context of addressing misinformation about the products.
The new article explains the matters related to general medical product communication in the context of addressing misinformation about the products.
The new article provides additional clarifications regarding specific aspects associated with recalls, such as appeals to relevant decisions or disposal for medical products.
The new article pays special attention to the classification of recall actions taken in order to ensure the continuous safety of medical devices allowed for marketing and use in the country.
The new article describes in detail how a recall action should be initiated, emphasizing the key points to be taken into consideration by the parties involved.
The new article is dedicated to the rapid alert system implemented by the authority in order to ensure the important safety-related information associated with healthcare products allowed for marketing and use in the country is communicated and shared without undue delay.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report